Form 10-Q Cellular Biomedicine For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cellular Biomedicine Group (CBMG) Misses Q2 EPS by 7c
August 14, 2015 7:03 AM EDTCellular Biomedicine Group (NASDAQ: CBMG) reported Q2 EPS of ($0.44), $0.07 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $657 thousand versus the consensus estimate of $650 thousand.
For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.
... More